Objectives: Exercise testing in patients with cystic fibrosis (CF) has become an important tool in assessing disease severity and predicting overall outcome. The reproducibility of maximal exercise testing was examined in adult subjects with stable CF. Methods: Nine subjects with CF underwent a total of three maximal exercise tests carried out under identical circumstances over a 28-day period. Oxygen uptake (V O 2 ), minute ventilation (V E), respiratory frequency (f), heart rate (HR), and arterial oxygen saturation (SaO 2 ) were measured at rest, at end exercise, and at 40% and 70% of maximum workload. Results: There were no significant differences in these measurements among the three tests. Reproducibility of exercise performance was assessed using the coefficient of variation. The mean within-subject coefficient of variation for test variables at end exercise are as follows: V O 2 , 6.9%; V E, 6.2%; f, 5.8%; HR, 3.0%; and SaO 2 , 1.1%. The mean within-subject coefficient of variation for test variables at 40% and 70% of maximal work rates are as follows: V O 2 , 5.2% and 4.6%; SaO 2 , 0.3% and 0.9%; HR, 4.0% and 3%; V E, 5.7% and 6.5%; and f, 5.8% and 7.2%, respectively. Conclusions: Variables measured during clinical cycle ergometer exercise testing in adult patients with stable CF are reproducible. No learning effect was found on repeated testing.
xercise testing in patients with cystic fibrosis (CF) has become an important tool in assessing disease severity and in predicting overall outcome. 1, 2 It is well documented that patients with CF have impaired exercise performance, as shown by reduced peak oxygen uptake (V o 2 max), reduced peak work rate (Wmax), and abnormal ventilatory and cardiovascular responses to exercise. [3] [4] [5] [6] [7] Despite the use of clinical exercise testing in CF patients, the reproducibility of maximal exercise testing has not, to our knowledge, been examined in these patients. In order to assess the clinical significance of repeated maximal exercise testing, we examined the reproducibility of clinical exercise testing in our patients with CF. Both group mean and individual responses to exercise were tested in adult patients with stable CF undergoing repeated incremental exercise tests under identical conditions.
Materials and Methods

Patients
Characteristics of our study population are outlined in Table 1 . The subjects (six men and three women) were recruited from outpatients in the National Adult Cystic Fibrosis Unit, St. Vincent's University Hospital. All subjects had clinical, radiologic, and physiologic evidence of CF-related lung disease, and they all had CF diagnoses based on clinical features, abnormal sweat test (sweat sodium and chloride Ͼ 60 mmol/L), and genotyping. All subjects were clinically stable for a period of 2 months prior to taking part in the study, and they all had no evidence of rheumatologic, neuromuscular, cardiac, or peripheral vascular disease, or any disease other than CF that might impair exercise tolerance.
Pulmonary function testing was carried out for each patient Protocol FEV 1 and FVC were measured before and after each exercise test. At least three well-coordinated maximal efforts were obtained, and the highest value obtained for each variable was recorded. The subjects underwent three exercise tests over a 28-day period, with each two tests separated by at least 7 days. Exercise was performed at the same time of day on each occasion. The subjects were asked to avoid strenuous activity for at least 24 h and food or caffeinated drinks for 2 h prior to exercise testing. All patients were instructed to take all of their maintenance medications but to avoid the use of ␤-agonist inhalers for at least 2 h prior to testing.
Testing was performed on an electrically braked cycle ergometer (Excalibur; Lode BV; Groningen, The Netherlands) while the subject breathed room air. After mounting the cycle ergometer, each patient put on a nose clip, inserted the mouthpiece, and had resting measurements taken over 1 min. The initial exercise workload was 15 W and was increased by 15 W/min in a ramp fashion until exhaustion. With the use of speedometer feedback, each subject chose the pedaling rate within a range of 50 to 70 revolutions/min. All subjects were instructed in an identical manner by the same operator for all exercise studies. The subjects were told that they should continue to exercise until they could exercise no more. No other type of encouragement was offered, and no communication was made with the subjects during the testing to ensure consistency of the protocol.
ECG leads attached to the chest enabled continuous monitoring of the heart rate (HR). Arterial oxygen saturation (Sao 2 ) was monitored by pulse oximetry (SAT-TRAK Pulse Oximeter; SensorMedics; Yorba Linda, CA). Each patient's mouthpiece was connected to a heated wire flowmeter (Mass Flow Sensor; SensorMedics). The flow signal was digitally integrated to give tidal volume (Vt), and respired gases were continually analyzed by rapidly responding oxygen (paramagnetic) and carbon dioxide (infrared) analyzers. All equipment was calibrated before each exercise study using calibration syringes and precision oxygen and carbon dioxide gas mixtures. All signals were continuously displayed breath by breath on a computer screen in real time during the exercise test. Data were also stored on computer hard disk for later analysis.
Data Analysis
Minute ventilation (V e), Vt, respiratory frequency (f), HR, oxygen uptake (V o 2 ), and carbon dioxide output (V co 2 ) were measured breath by breath using standard formulas. 10,11 V e and Vt were expressed at body temperature and pressure, saturated with water vapor; V o 2 and V co 2 were expressed at standard temperature pressure, dry. Predicted V o 2 max during exercise was calculated as follows 10 :
where height (ht) is in meters, age is in years, and S represents gender (S ϭ 0 for men and S ϭ 1 for women). Predicted peak HR was calculated as follows 10 : *Data are given as mean (SD). Maximum V o 2 ϭ maximum oxygen consumption at end exercise; Maximum HR ϭ maximum heart rate at end exercise. †V e/MVV and V e/V o 2 are measured at end exercise.
Maximum voluntary ventilation (MVV) was estimated as follows 12 :
Sense of dyspnea was assessed using the Borg scale 13 in response to the question, "How breathless do you feel?" with the subject pointing to the appropriate number on the scale. Leg discomfort was assessed using the Borg scale, in response to the question, "How much leg discomfort do you feel?" Each patient was also asked the reason for stopping exercise immediately after each exercise test.
Statistical Analysis
Data collected at rest, at maximal exercise, and at two matched submaximal work rates were used in the analysis. Submaximal work rates of 40% and 70% of the highest Wmax achieved during the three tests were chosen for each patient. Comparisons were then made at matched work rates for the three studies.
Statistical significance of group mean data from the three experiment days were determined by repeated-measures analysis of variance. 14 The variability of subject results for the three experiments was assessed using the coefficient of variation. The coefficient of variation was derived by dividing the SD by the mean. 15 Analysis of the Borg scale was performed using Wilcox- 
Analysis of our data showed that the sample size was sufficient to detect a 12% increase in both V o 2 max (0.18 L/min) and Wmax (16 W) throughout the three exercise tests with 90% power. 16 
Results
All subjects completed each exercise test without any complications, and no exercise test was terminated by the physician.
Resting Results
Analysis of group mean data collected before exercise showed no significant difference in baseline spirometric values. Mean FEV 1 was 56% predicted (range, 30 to 82%). Mean FVC was 76% predicted (range, 55 to 100%). The mean coefficient of variation for FEV 1 was 4.7% (range, 1.0 to 8.8%), and for FVC, 5.2% (range, 2.0 to 9.4%). The mean resting Sao 2 was 95% (range, 93 to 97%). There was no significant difference in baseline values of V o 2 , V co 2 , V e, Vt, f, Sao 2 , and HR in the three separate studies.
Exercise Results
All patients had evidence of impaired exercise tolerance. Mean (Ϯ SD) values for V o 2 max as percent predicted was 62 Ϯ 8% (range, 51 to 71%). The mean maximal heart rate was 86 Ϯ 6% (range, 78 to 98%) of predicted. Mean oxygen desaturation was 4 Ϯ 2.7% (range, 1 to 9%). The three subjects with the lowest FEV 1 had significant desaturation of Ͼ 5%. The V e/MVV ratio was 98 Ϯ 27% (range, 57 to 124%). Reasons for discontinuing exercise were dyspnea (three patients), leg discomfort (four patients), or both (two patients). This did not vary from test to test.
Eight of the nine patients reached their anaerobic threshold as calculated using the modified V-slope method. 17 Table 2 lists the group mean data collected at end of exercise. There was no significant difference at end of exercise in V o 2 , V co 2 , V e, Vt, f, HR, Sao 2 , exercise time, or work rate. In addition, there was no significant difference in any variables at 40% Wmax or 70% Wmax.
Exercise Variability
The mean within-subject coefficients of variation measured during exercise are shown in Table 3 . Values obtained at rest, end exercise, and 40% and 70% Wmax are shown.
The mean within-subject coefficient of variation at end of exercise for V o 2 max was 6.9% (range, 1 to 13% throughout exercise); for Sao 2 , 1.1% (range, 0 to 5% throughout exercise); and HR, 3.0% (range, 1.7 to 8.0% throughout exercise). The mean within-subject coefficient of variation for V e at end exercise was 6.2% (range, 3.0 to 12.3% throughout exercise); for Vt, 3.8% (range, 1 to 15% throughout exercise); and for f, 5.8% (range, 2 to 15% throughout exercise).
The mean within-subject coefficient of variation for exercise duration was 4.7% (range, 1.9 to 13.2%) and for Wmax, 6.0% (range, 0.6 to 14.0%). At end exercise, the mean coefficient of variation for Borg scale leg discomfort was 8.4% (range, 0 to 25%) and for Borg scale dyspnea, 11.3% (range, 0 to 25%). Figure 1 shows each subject's V o 2 max and exercise duration for each of the three exercise tests. Figure 2 is a graphic representation of V o 2 against V e throughout the exercise tests for three patients with varying degrees of lung dysfunction. The relationship between V o 2 and V e is similar in each subject's three tests.
Discussion
As in previous studies [1] [2] [3] [4] [5] [6] [7] of exercise in patients with CF, our patients showed reduced exercise tolerance with reduced maximal workload and V o 2 max. Our patients had increased ventilatory requirements with a high ventilation (V e), an elevated ventilatory equivalent for oxygen (V e/V o 2 ) and an increased V e/MVV at end exercise. Two patients reached their predicted maximum HR. The three patients with the lowest FEV 1 showed significant oxygen desaturation during exercise.
We looked at the reproducibility and withinsubject variability of measured parameters during maximal incremental exercise testing in our adult CF population. This variability, as measured by the coefficient of variation, is similar to that measured in studies carried out on healthy subjects and in patients with chronic airflow limitation (CAL), interstitial lung disease (ILD), and cardiac failure.
Previous studies have examined the reproducibility of maximal exercise testing. Garrard and Emmons 18 found some diurnal variation in their healthy subjects, with a coefficient of variation during maximal exercise testing for V o 2 max of 8.4%; V e, 12.0%; and HR, 3.8%. Nordrehaug et al 19 examined the reproducibility of maximal treadmill exercise testing in healthy subjects and found a coefficient of variation for V o 2 max of 5.0%; V e, 7.0%; and HR, 3.0%. They also found that the variability at end exercise was less than that at submaximal levels of exercise.
The reproducibility of repeated exercise testing has also been extensively examined in patients with CAL. 26 showed significant increases in exercise duration and workload with repeated exercise testing.
Our patients with CF had a coefficient of variation for FEV 1 of 4.7%; V o 2 max, 6.9%; and V e, 6.2%. This is similar to the findings of Nordrehaug et al 19 in healthy subjects. Comparison with patients with respiratory disease shows adult patients with CF to have variability slightly greater than ILD patients but less variability than CAL patients.
All of our patients stated that they made a maximal effort and exercised until exhaustion. The Borg scores at end exercise (dyspnea, 4.1 Ϯ 1.1; leg discomfort, 3.8 Ϯ 1.1) are similar to those in other studies assessing breathlessness at end exercise in other diseases. Marciniuk et al 24 found that patients with ILD had mean Borg scores of 4.5 at end exercise. In their study of added dead space during maximal incremental exercise testing in ILD, the control group of the study (with no dead space) had mean scores of 5.0 at end exercise. 27 Studies looking at the reproducibility of Borg scoring after maximal exercise testing in patients with CAL have also found a mean of 5.0 after repeated testing. 28 Other factors favoring a maximal effort by our patients is that the majority of the patients either reached their maximal predicted HR at end exercise or showed a high (Ͼ 90%) V e/MVV ratio at end exercise. Patients with low Borg scores (Յ 3) for dyspnea all gave higher scores (Ͼ 4) for leg discomfort and vice versa. Finally, all our exercise tests were observed by a physician who felt that, at end exercise, all the patients had given maximal effort.
There are limitations to the current assessment of factors that limit exercise, 29 but allowing for these, one patient appeared primarily limited by cardiac factors, seven patients appeared limited by respiratory factors, and one appeared limited by a combination of both. The patients with the most severe CF were limited primarily by respiratory factors, with V e/MVV ratios Ͼ 90% and low predicted HR, while the two patients with the mildest disease were primarily limited by cardiac and/or respiratory factors, reaching Ͼ 97% predicted maximum HR.
In clinical practice, changes in individual patients are more useful than changes within groups of patients. We looked at within-subject variation and how this could be applied in a clinical setting. Our results indicate that changes of 13% in exercise duration, 19% in V o 2 max, and at least 17% in peak V e are unlikely to occur by chance. 14 In conclusion, we have found that parameters measured in repeated cycle ergometer exercise testing are reproducible; this variability is similar to that seen in healthy subjects and in patients with CAL and ILD. There was no obvious learning effect between the tests. We also noted that the reproducibility of spirometric measurements (FEV 1 and FVC) before and after exercise was similar to that of healthy subjects and, although slightly less than that measured in ILD, is more reproducible than that seen in CAL. In addition, we looked at exercise testing at submaximal workloads (40% and 70% Wmax) and also found this to be reproducible.
Our patients showed no learning or training effect with repeated exercise testing, indicating that practice testing is not necessary in patients with stable CF who have not previously used a cycle ergometer.
